Research reveals Orkney cancer gene link—now testing will take place
One in 100 people who have grandparents from Orkney have a gene variant that causes a higher risk of developing breast and ovarian cancer, a study has found.
Mar 17, 2023
0
13
One in 100 people who have grandparents from Orkney have a gene variant that causes a higher risk of developing breast and ovarian cancer, a study has found.
Mar 17, 2023
0
13
Certain chemotherapy-resistant ovarian cancer cells protect neighboring cancer cells by sending signals that induce resistance, according to a new study from University of Pittsburgh and UPMC researchers that may help explain ...
Mar 3, 2023
1
12
Testing a population for multiple genes at once will be limited in its ability to accurately predict disease risk, argues a new paper involving UCL's Professor Aroon Hingorani.
Mar 3, 2023
0
3
Although genetic mutations in BRCA1 or BRCA2 are associated with a younger onset of breast and ovarian cancer, women with these genetic mutations continue to face a high risk of cancer incidence after age 50, even if they ...
Feb 24, 2023
0
13
Genetic counseling and genetic testing for mutations in certain genes such as BRCA1 and BRCA2 genes—can help people understand their risk of certain types of cancer that can run in families, and improve outcomes through ...
Feb 15, 2023
0
2
In recent years, a mass spectrometry process that can detect the amounts of drugs in a biological sample, such as blood, has become a powerful diagnostic tool for helping medical professionals identify and monitor levels ...
Feb 10, 2023
0
59
New QIMR Berghofer research has found that low-dose aspirin may improve ovarian cancer survival.
Feb 7, 2023
1
108
CAR T-cell therapy, a certain kind of cancer treatment in which the immune system's T cells are programmed to attack tumor cells, is effective in mice with ovarian cancer, according to a study published in The Journal for ...
Feb 6, 2023
0
17
More women, even those at low risk for ovarian cancer, who have finished having children should have their fallopian tubes removed as a precaution to prevent the deadly disease, a leading research group has advised.
Feb 1, 2023
0
13
In an internationally conducted clinical trial lead by Dana-Farber involving patients with recurrent ovarian cancer that is resistant to platinum therapy, a novel conjugate therapy called mirvetuximab soravtansine resulted ...
Jan 31, 2023
0
73